Fundz
A company that just raised surges hiring in 30 to 60 days. Fundz shows you the money, about a month before the job ad.See it live →

Adora Life Science Appoints Dr. Clinton D. Morgan as Chief Medical Officer

PRIVATESep 16, 2026•about 3 hours ago

Position

Chief Medical Officer

Company

Adora Life Science

Dr. Clinton D. Morgan
FranklinBiotechnologyHealth Care

Description

Adora Life Science announced the appointment of Dr. Clinton D. Morgan as its full-time Chief Medical Officer, effective November 1, 2026

Company Information

Company

Adora Life Science

Location

Franklin, Tennessee, United States

About

Adora Life Science is developing a new class of matrix restoration therapeutics based on repurposing PSGAG, a chondroitin sulfate derived biopolymer. This biopolymer has over 40 years of veterinary use as a disease-modifying antiarthritic drug. The company focuses on protecting and restoring extracellular matrix degeneration, which is an early driver of disease in cartilage, skin, and soft tissue.

Don't miss Adora Life Science's next move

Get an email the moment Adora Life Science changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Adora Life Science's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Adora Life Science changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.